Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 175

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?

Wyss, Markus, Schulze, Andreas·2002·Neuroscience
DOI 10.1016/s0306-4522(02)00088-x
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0306-4522(02)00088-x

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 123

  1. Andreassen, 2001, Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation, J. Neurochem., 77, 383, 10.1046/j.1471-4159.2001.00188.x · DOI
  2. Bajuk, 2001, Therapeutic comparison of metformin and creatine in the glycemic control of patients with type 2 diabetes mellitus, Diabetes, 50, A430
  3. Balestrino, 1999, Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship, Brain Res., 816, 124, 10.1016/S0006-8993(98)01131-7 · DOI
  4. Benzi, 2000, Is there a rationale for the use of creatine either as nutritional supplementation or drug administration in humans participating in a sport?, Pharmacol. Res., 41, 255, 10.1006/phrs.1999.0618 · DOI
  5. Benzi, 2001, Creatine as nutritional supplementation and medicinal product, J. Sports Med. Phys. Fitness, 41, 1
  6. Bermon, 1998, Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults, Acta Physiol. Scand., 164, 147, 10.1046/j.1365-201X.1998.00427.x · DOI · Paper page
  7. Bessman, 1981, Transport of energy in muscle: the phosphorylcreatine shuttle, Science, 211, 448, 10.1126/science.6450446 · DOI · Paper page
  8. Bianchi, 2000, Reversible brain creatine deficiency in two sisters with normal blood creatine level, Ann. Neurol., 47, 511, 10.1002/1531-8249(200004)47:4<511::AID-ANA15>3.0.CO;2-N · DOI
  9. Boehm, 2000, Glycolysis supports calcium uptake by the sarcoplasmic reticulum in skinned ventricular fibres of mice deficient in mitochondrial and cytosolic creatine kinase, J. Mol. Cell. Cardiol., 32, 891, 10.1006/jmcc.2000.1130 · DOI
  10. Boers, 1998, Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment, Eur. J. Pediatr., 157, S127, 10.1007/PL00014292 · DOI
  11. Borchert, 1999, Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies, Muscle Nerve, 22, 1299, 10.1002/(SICI)1097-4598(199909)22:9<1299::AID-MUS24>3.0.CO;2-4 · DOI · Paper page
  12. Braissant, 2001, Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study, Mol. Brain Res., 86, 193, 10.1016/S0169-328X(00)00269-2 · DOI
  13. Brustovetsky, 2001, On the mechanisms of neuroprotection by creatine and phosphocreatine, J. Neurochem., 76, 425, 10.1046/j.1471-4159.2001.00052.x · DOI
  14. Butterfield, 2001, Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins, Mech. Ageing Dev., 122, 945, 10.1016/S0047-6374(01)00249-4 · DOI · Paper page
  15. Carducci, 2001, Automated high-performance liquid chromatographic method for the determination of guanidinoacetic acid in dried blood spots: a tool for early diagnosis of guanidinoacetate methyltransferase deficiency, J. Chromatogr., 755B, 343, 10.1016/S0378-4347(01)00052-4 · DOI
  16. Carrasco, 2001, Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels, Proc. Natl. Acad. Sci. USA, 98, 7623, 10.1073/pnas.121038198 · DOI
  17. Cecil, K.M., Degrauw, T.J., 2001. The clinical syndrome of creatine transporter deficiency. Oral presentation, 6th International Conference on Guanidino Compounds in Biology and Medicine, Cincinnati, OH, August 31–September 3.
  18. Cecil, 2001, Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?, Ann. Neurol., 49, 401, 10.1002/ana.79 · DOI
  19. Chevreul, 1835, Sur la composition chimique du bouillon de viandes, J. Pharm. Sci. Accessoires, 21, 231
  20. De Groof, 2001, Changes in glycolytic network and mitochondrial design in creatine kinase-deficient muscles, Muscle Nerve, 24, 1188, 10.1002/mus.1131 · DOI
  21. Deshpande, 1997, 3-Nitropropionic acid increases the intracellular Ca2+ in cultured astrocytes by reverse operation of the Na+-Ca2+ exchanger, Exp. Neurol., 145, 38, 10.1006/exnr.1997.6457 · DOI
  22. Dierkes, 2001, Factors explaining the difference of total homocysteine between men and women in the European investigation into cancer and nutrition Potsdam study, Metabolism, 50, 640, 10.1053/meta.2001.23286 · DOI
  23. Doherty, 2001, Creatine monohydrate does not increase strength in patients with hereditary neuropathy, Neurology, 57, 559, 10.1212/WNL.57.3.559 · DOI
  24. Dzeja, 1996, Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle, J. Biol. Chem., 271, 12847, 10.1074/jbc.271.22.12847 · DOI
  25. Eggleton, 1927, The inorganic phopshate and a labile form of organic phosphate in the gastrocnemius of the frog, Biochem. J., 21, 190, 10.1042/bj0210190 · DOI
  26. Ensenauer, 2001, Presence of muscle creatine in a patient with guanidinoacetate methyltransferase (GAMT) deficiency, J. Inherit. Metab. Dis., 23, 212
  27. Fiske, 1927, The nature of the ‘inorganic phosphate’ in voluntary muscle, Science, 65, 401, 10.1126/science.65.1686.401 · DOI
  28. Gorselink, 2001, Murine muscles deficient in creatine kinase tolerate repeated series of high-intensity contractions, Pflügers Arch. Eur. J. Physiol., 443, 274, 10.1007/s004240100687 · DOI
  29. Graham, 1999, Creatine: a review of efficacy and safety, J. Am. Pharmacol. Assoc., 39, 803
  30. Gramsbergen, 2000, Pyruvate protects against 3-nitropropionic acid neurotoxicity in corticostriatal slice cultures, NeuroReport, 11, 2743, 10.1097/00001756-200008210-00027 · DOI
  31. Greenwood, 2000, Creatine supplementation patterns and perceived effects in select division I collegiate athletes, Clin. J. Sport Med., 10, 191, 10.1097/00042752-200007000-00007 · DOI · Paper page
  32. Guerrero-Ontiveros, 1998, Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo down-regulation of the expression of creatine transporter isoforms in skeletal muscle, Mol. Cell. Biochem., 184, 427, 10.1023/A:1006895414925 · DOI
  33. Hankey, 1999, Homocysteine and vascular disease, Lancet, 354, 407, 10.1016/S0140-6736(98)11058-9 · DOI · Paper page
  34. Heinänen, 1999, Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia, Eur. J. Clin. Invest., 29, 1060, 10.1046/j.1365-2362.1999.00569.x · DOI
  35. Hespel, 2001, Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans, J. Physiol., 536.2, 625, 10.1111/j.1469-7793.2001.0625c.xd · DOI · Paper page
  36. Hespel, P., Op 't Eijnde, B., Derave, W., Richter, E.A., 2001b. Creatine supplementation: exploring the role of the creatine kinase/phosphocreatine system in human muscle. Can. J. Appl. Physiol. 26 (Suppl.), S79–S102. · DOI
  37. Holtzman, 1999, In vivo development of brain phosphocreatine in normal and creatine-treated rabbit pups, J. Neurochem., 73, 2477, 10.1046/j.1471-4159.1999.0732477.x · DOI
  38. Holtzman, 1989, Brain creatine phosphate and creatine kinase in mice fed an analogue of creatine, Brain Res., 483, 68, 10.1016/0006-8993(89)90035-8 · DOI
  39. Holtzman, 1998, Creatine increases survival and suppresses seizures in the hypoxic immature rat, Pediatr. Res., 44, 410, 10.1203/00006450-199809000-00024 · DOI
  40. Ikeda, 2000, Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse, ALS, 1, 207, 10.1080/14660820050515205 · DOI
  41. Item, 2001, Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans, Am. J. Hum. Genet., 69, 1127, 10.1086/323765 · DOI · Paper page
  42. Jacobson, 2001, Nutrition practices and knowledge of college varsity athletes: a follow-up, J. Strength Cond. Res., 15, 63
  43. Janssen, 2000, Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement, EMBO J., 19, 6371, 10.1093/emboj/19.23.6371 · DOI
  44. Juhn, 1999, Oral creatine supplementation in male collegiate athletes: a survey of dosing habits and side effects, J. Am. Diet. Assoc., 99, 593, 10.1016/S0002-8223(99)00145-5 · DOI
  45. Kaemmerer, 2001, Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype, Neuroscience, 103, 713, 10.1016/S0306-4522(01)00017-3 · DOI
  46. Kay, 2000, Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ, J. Biol. Chem., 275, 6937, 10.1074/jbc.275.10.6937 · DOI · Paper page
  47. Kekelidze, 2001, Altered brain phosphocreatine and ATP regulation when mitochondrial creatine kinase is absent, J. Neurosci. Res., 66, 866, 10.1002/jnr.10060 · DOI
  48. Klivenyi, 1999, Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis, Nature Med., 5, 347, 10.1038/6568 · DOI · Paper page
  49. Klopstock, 2000, A placebo-controlled crossover trial of creatine in mitochondrial diseases, Neurology, 55, 1748, 10.1212/WNL.55.11.1748 · DOI · Paper page
  50. Kölker, 2001, Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons, Pediatr. Res., 50, 76, 10.1203/00006450-200107000-00015 · DOI
  51. Kornacker, 2001, Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis, Int. J. Cancer, 94, 513, 10.1002/ijc.1502 · DOI
  52. Koshy, 1999, Interstitial nephritis in a patient taking creatine, New Engl. J. Med., 340, 814, 10.1056/NEJM199903113401017 · DOI
  53. LaBotz, 1999, Creatine supplement use in an NCAA division I athletic program, Clin. J. Sport Med., 9, 167, 10.1097/00042752-199907000-00009 · DOI
  54. Larsen, 2001, Synthesis and biological activity of analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid: discovery of a novel aminoguanidinoacetic acid antidiabetic agent, J. Med. Chem., 44, 1217, 10.1021/jm000095f · DOI
  55. Leuzzi, 2000, Brain creatine depletion: guanidinoacetate methyltransferase deficiency (improving with creatine supplementation), Neurology, 55, 1407, 10.1212/WNL.55.9.1407 · DOI
  56. Lohmann, 1934, Über die enzymatische Aufspaltung der Kreatinphosphorsäure; zugleich ein Beitrag zum Chemismus der Muskelkontraktion, Biochem. Z., 271, 264
  57. Lundsgaard, 1930, Weitere Untersuchungen über Muskelkontraktionen ohne Milchsäurebildung, Biochem. Z., 227, 51
  58. Lussier-Cacan, 1996, Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits, Am. J. Clin. Nutr., 64, 587, 10.1093/ajcn/64.4.587 · DOI
  59. Mahajan, 2000, Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton, Proc. Natl. Acad. Sci. USA, 97, 12062, 10.1073/pnas.97.22.12062 · DOI
  60. Malcon, 2000, Neuroprotective effects of creatine administration against NMDA and malonate toxicity, Brain Res., 860, 195, 10.1016/S0006-8993(00)02038-2 · DOI
  61. Manabe, 1992, Formation of PhIP in a mixture of creatinine, phenylalanine and sugar or aldehyde by aqueous heating, Carcinogenesis, 13, 827, 10.1093/carcin/13.5.827 · DOI
  62. Massieu, 2001, Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates, Neuroscience, 106, 669, 10.1016/S0306-4522(01)00323-2 · DOI
  63. Matthews, 1999, Creatine and cyclocreatine attenuate MPTP neurotoxicity, Exp. Neurol., 157, 142, 10.1006/exnr.1999.7049 · DOI · Paper page
  64. Matthews, 1998, Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington’s disease, J. Neurosci., 18, 156, 10.1523/JNEUROSCI.18-01-00156.1998 · DOI · Paper page
  65. Mazzini, 2001, Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results, J. Neurol. Sci., 191, 139, 10.1016/S0022-510X(01)00611-6 · DOI
  66. McCarty, 2001, Supplemental creatine may decrease serum homocysteine and abolish the homocysteine ‘gender gap’ by suppressing endogenous creatine synthesis, Med. Hypotheses, 56, 5, 10.1054/mehy.1999.1014 · DOI
  67. McGuine, 2001, Creatine supplementation in high school football players, Clin. J. Sport Med., 11, 247, 10.1097/00042752-200110000-00007 · DOI · Paper page
  68. Mertschenk, 2001, Health assessment of creatine as a dietary supplement (in German), Dtsch. Lebensm.-Rundsch., 97, 250
  69. Mihic, 2000, Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women, Med. Sci. Sports Exerc., 31, 291, 10.1097/00005768-200002000-00007 · DOI · Paper page
  70. Miller, 2000, Hyperhomocyst(e)inemia induces multiorgan damage, Heart Vessels, 15, 135, 10.1007/s003800070030 · DOI
  71. Mudd, 1980, Labile methyl group balances in the human: the role of sarcosine, Metabolism, 29, 707, 10.1016/0026-0495(80)90192-4 · DOI
  72. Näntö-Salonen, 1999, Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithenemia, Neurology, 53, 303, 10.1212/WNL.53.2.303 · DOI · Paper page
  73. Ness, 2001, Does supplemental creatine prevent herpes recurrences?, Med. Hypotheses, 57, 310, 10.1054/mehy.2001.1319 · DOI
  74. Neubauer, 1998, Manipulating creatine levels post-myocardial infarction – chronic effects on left ventricular remodeling, Magn. Reson. Mater. Phys. Biol. Med., 6, 126, 10.1016/S1352-8661(98)00038-6 · DOI
  75. Passaquin, 2002, Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice, Neuromusc. Disord., 12, 174, 10.1016/S0960-8966(01)00273-5 · DOI · Paper page
  76. Persky, 2001, Clinical pharmacology of the dietary supplement creatine monohydrate, Pharmacol. Rev., 53, 161
  77. Poortmans, 1997, Effect of short-term creatine supplementation on renal responses in men, Eur. J. Appl. Physiol. Occup. Physiol., 76, 566, 10.1007/s004210050291 · DOI · Paper page
  78. Poortmans, 1999, Long-term oral creatine supplementation does not impair renal function in healthy athletes, Med. Sci. Sports Exerc., 31, 1108, 10.1097/00005768-199908000-00005 · DOI · Paper page
  79. Poortmans, 2000, Adverse effects of creatine supplementation: fact or fiction?, Sports Med., 30, 155, 10.2165/00007256-200030030-00002 · DOI · Paper page
  80. Pucar, 2001, Cellular energetics in the preconditioned state: protective role for phosphotransfer reactions captured by 18O-assisted 31P NMR, J. Biol. Chem., 276, 44812, 10.1074/jbc.M104425200 · DOI
  81. Pucar, 2000, Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress, J. Biol. Chem., 275, 41424, 10.1074/jbc.M007903200 · DOI
  82. Rauh, 2001, Homocysteine concentrations in a German cohort of 500 individuals: reference ranges and determinants of plasma levels in healthy children and their parents, Amino Acids, 20, 409, 10.1007/s007260170037 · DOI
  83. Robinson, 2000, Acute quadriceps compartment syndrome and rhabdomyolysis in a weight lifter using high-dose creatine supplementation, J. Am. Board Fam. Pract., 13, 134, 10.3122/15572625-13-2-134 · DOI
  84. Robinson, 2000, Dietary creatine supplementation does not affect some haematological indices, or indices of muscle damage and hepatic and renal function, Br. J. Sports Med., 34, 284, 10.1136/bjsm.34.4.284 · DOI · Paper page
  85. Saks, 1978, Role of creatine phosphokinase in cellular function and metabolism, Can. J. Physiol. Pharmacol., 56, 691, 10.1139/y78-113 · DOI · Paper page
  86. Salomons, G.S., 2001. X-linked creatine transporter defect: the first two families. Oral presentation, 6th International Conference on Guanidino Compounds in Biology and Medicine, Cincinnati, OH, August 31–September 3.
  87. Salomons, 2001, X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome, Am. J. Hum. Genet., 68, 1497, 10.1086/320595 · DOI · Paper page
  88. Schilling, 2001, Creatine supplementation and health variables: a retrospective study, Med. Sci. Sports Exerc., 33, 183, 10.1097/00005768-200102000-00002 · DOI · Paper page
  89. Schulze, A., 2001. Creatine-deficiency syndromes. Oral presentation, 6th International Conference on Guanidino Compounds in Biology and Medicine, Cincinnati, OH, August 31–September 3.
  90. Schulze, 2001, Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation, Mol. Genet. Metab., 74, 413, 10.1006/mgme.2001.3257 · DOI
  91. Schulze, 1997, Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism, J. Pediatr., 131, 626, 10.1016/S0022-3476(97)70075-1 · DOI
  92. Schulze, 1998, Therapeutic trial of arginine restriction in creatine deficiency syndrome, Eur. J. Pediatr., 157, 606, 10.1007/s004310050890 · DOI
  93. Selhub, 1999, Homocysteine metabolism, Annu. Rev. Nutr., 19, 217, 10.1146/annurev.nutr.19.1.217 · DOI · Paper page
  94. Shear, 2000, Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats, NeuroReport, 11, 1833, 10.1097/00001756-200006260-00007 · DOI
  95. Shortland, 2001, LCHAD deficiency treated with creatine, J. Inherit. Metab. Dis., 24, 71
  96. Snow, 2001, Creatine and the creatine transporter: a review, Mol. Cell. Biochem., 224, 169, 10.1023/A:1011908606819 · DOI
  97. Stead, 2001, Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate, Am. J. Physiol., 281, E1095
  98. Steeghs, 1997, Use of gene targeting for compromising energy homeostasis in neuromuscular tissues: the role of sarcomeric mitochondrial creatine kinase, J. Neurosci. Methods, 71, 29, 10.1016/S0165-0270(96)00124-0 · DOI
  99. Steeghs, 1995, Mice deficient in ubiquitous mitochondrial creatine kinase are viable and fertile, Biochim. Biophys. Acta, 1230, 130, 10.1016/0005-2728(95)00044-J · DOI
  100. Steenge, 2001, The effect of creatine and resistance training on plasma homocysteine concentration in healthy volunteers, Arch. Intern. Med., 161, 1455, 10.1001/archinte.161.11.1455 · DOI
  101. Stout, 2001, Effects of resistance exercise and creatine supplementation on myasthenia gravis: a case study, Med. Sci. Sports Exerc., 33, 869, 10.1097/00005768-200106000-00003 · DOI · Paper page
  102. Sullivan, 2000, Dietary supplement creatine protects against traumatic brain injury, Ann. Neurol., 48, 723, 10.1002/1531-8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W · DOI
  103. Tarnopolsky, 2001, Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders, Ann. Neurol., 49, 561, 10.1002/ana.1028 · DOI · Paper page
  104. Tarnopolsky, 1999, Creatine monohydrate increases strength in patients with neuromuscular disease, Neurology, 52, 854, 10.1212/WNL.52.4.854 · DOI · Paper page
  105. Tarnopolsky, 1997, A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies, Muscle Nerve, 20, 1502, 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C · DOI · Paper page
  106. Terjung, 2000, The physiological and health effects of oral creatine supplementation, Med. Sci. Sports Exerc., 32, 706, 10.1097/00005768-200003000-00024 · DOI · Paper page
  107. Tombes, 1985, Metabolite channeling: a phosphorylcreatine shuttle to mediate high energy phosphate transport between sperm mitochondrion and tail, Cell, 41, 325, 10.1016/0092-8674(85)90085-6 · DOI
  108. Toner, 1999, Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia, Brain Res. Bull., 48, 395, 10.1016/S0361-9230(99)00016-7 · DOI
  109. Vaillancourt, 2001, Synthesis and biological activity of aminoguanidine and diaminoguanidine analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid, J. Med. Chem., 44, 1231, 10.1021/jm000094n · DOI
  110. van Deursen, 1993, Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity, Cell, 74, 621, 10.1016/0092-8674(93)90510-W · DOI · Paper page
  111. van der Knaap, 2000, Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect, Ann. Neurol., 47, 540, 10.1002/1531-8249(200004)47:4<540::AID-ANA23>3.0.CO;2-K · DOI · Paper page
  112. Volek, 2000, No effect of heavy resistance training and creatine supplementation on blood lipids, Int. J. Sport Nutr. Exerc. Metab., 10, 144, 10.1123/ijsnem.10.2.144 · DOI · Paper page
  113. von Figura, K., Hanefeld, F., Isbrandt, D., Stöckler-Ipsiroglu, S., 2000. Guanidinoacetate methyltransferase deficiency. In: Scriver, C.R., Beaudet, A., Sly, W.S., Valle, D. (Eds.), The Metabolic and Molecular Basis of Inherited Disease. McGraw Hill, New York, pp. 1897–1908.
  114. Vorgerd, 2000, Creatine therapy in myophosphorylase deficiency (McArdle disease). A placebo-controlled crossover trial, Arch. Neurol., 57, 956, 10.1001/archneur.57.7.956 · DOI · Paper page
  115. Walter, 2000, Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study, Neurology, 54, 1848, 10.1212/WNL.54.9.1848 · DOI · Paper page
  116. Watanabe, A., Kato, N., Kato, T., 2002. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci. Res., in press. · DOI · Paper page
  117. Watchko, 2000, Myofibrillar or mitochondrial creatine kinase deficiency alone does not impair mouse diaphragm isotonic function, J. Appl. Physiol., 88, 973, 10.1152/jappl.2000.88.3.973 · DOI
  118. Welch, 1998, Mechanisms of disease: homocysteine and atherothrombosis, New Engl. J. Med., 338, 1042, 10.1056/NEJM199804093381507 · DOI · Paper page
  119. Wieringa, B., 2001. Coupling between the CK pathway and other networks for high-energy phosphoryl (ATP) transfer in mammalian cells. Oral presentation, 6th International Conference on Guanidino Compounds in Biology and Medicine, Cincinnati, OH, August 31–September 3.
  120. Wilken, 1998, Creatine protects the central respiratory network of mammals under anoxid conditions, Pediatr. Res., 43, 8, 10.1203/00006450-199801000-00002 · DOI
  121. Wilken, 2000, Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation, Arch. Dis. Child. Fetal Neonatal Edn., 82, F224, 10.1136/fn.82.3.F224 · DOI
  122. Wyss, 1998, The therapeutic potential of oral creatine supplementation in muscle disease, Med. Hypotheses, 51, 333, 10.1016/S0306-9877(98)90058-5 · DOI
  123. Zeleznikar, 1995, Adenylate kinase-catalyzed phosphoryl transfer couples ATP utilization with its generation by glycolysis in intact muscle, J. Biol. Chem., 270, 7311, 10.1074/jbc.270.13.7311 · DOI

Cited by

See all 175

Metadata

Authors
Wyss, M., & Schulze, A.
Venue
Neuroscience
Publisher
Elsevier BV
Published
2002-06
Volume
112
Issue
2
Pages
243-260
ISSN
0306-4522
DOI
10.1016/s0306-4522(02)00088-x
Cited by
175
References
21
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.